KELLY ALBERDA: Open Payments
NPI 1972525376 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 43 payments from 14 companies in 2025. Trend: 2023 $1,011 · 2024 $983 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $244 |
| ABBVIE INC. | 5 | $89 |
| Lilly USA, LLC | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| PFIZER INC. | 3 | $54 |
| Abbott Laboratories | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29 |
| Gilead Sciences, Inc. | 1 | $25 |
| SANOFI PASTEUR INC. | 1 | $23 |
| ViiV Healthcare Company | 1 | $22 |
Products named: Rybelsus, AIRSUPRA, Ozempic, MOUNJARO, UBRELVY, JARDIANCE, FREESTYLE LIBRE 3, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
